Page last updated: 2024-08-23

azoxymethane and scopolamine hydrobromide

azoxymethane has been researched along with scopolamine hydrobromide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Belo, A; Cheng, K; Drachenberg, C; Khurana, S; Raufman, JP; Samimi, R; Shah, N; Shant, J; Shiu, B; Wess, J	1

Other Studies

1 other study(ies) available for azoxymethane and scopolamine hydrobromide

Article	Year
Scopolamine treatment and muscarinic receptor subtype-3 gene ablation augment azoxymethane-induced murine liver injury. The Journal of pharmacology and experimental therapeutics, 2010, Volume: 333, Issue:3 Topics: Animals; Apoptosis; Azoxymethane; Cell Proliferation; Chemical and Drug Induced Liver Injury; Hepatocytes; Hyperplasia; Immunohistochemistry; Liver; Liver Cirrhosis; Liver Regeneration; Mice; Mice, Knockout; Muscarinic Antagonists; Receptor, Muscarinic M3; Scopolamine	2010

Article

Year

Scopolamine treatment and muscarinic receptor subtype-3 gene ablation augment azoxymethane-induced murine liver injury.

The Journal of pharmacology and experimental therapeutics, 2010, Volume: 333, Issue:3

Topics: Animals; Apoptosis; Azoxymethane; Cell Proliferation; Chemical and Drug Induced Liver Injury; Hepatocytes; Hyperplasia; Immunohistochemistry; Liver; Liver Cirrhosis; Liver Regeneration; Mice; Mice, Knockout; Muscarinic Antagonists; Receptor, Muscarinic M3; Scopolamine

2010